UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | E | H | K | M | N | S | V
Number of items: 11.


Adams, D; Ando, Y; Beirão, JM; Coelho, T; Gertz, MA; Gillmore, JD; Hawkins, PN; ... Merlini, G; + view all (2020) Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. Journal of Neurology 10.1007/s00415-019-09688-0. (In press). Green open access

Arbore, G; Ong, VH; Costantini, B; Denton, CP; Abraham, D; Placais, L; Blighe, K; ... Hourcade, DE; + view all (2020) Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis. Cellular & Molecular Immunology 10.1038/s41423-019-0360-8. (In press).


Ehrenstein, M; (2020) Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT LUPUS) protocol: A prospective multi-centre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial. BMJ Open 10.1136/bmjopen-2019-032569. (In press).


Hanly, JG; Li, Q; Su, L; Urowitz, MB; Gordon, C; Bae, S-C; Romero-Diaz, J; ... Farewell, V; + view all (2020) Peripheral nervous system disease in Systemic Lupus Erythematosus: Results from an international, inception cohort study. Arthritis Rheumatol , 72 (1) pp. 67-77. 10.1002/art.41070.


Khanna, D; Spino, C; Johnson, S; Chung, L; Whitfield, M; Denton, CP; Berrocal, V; ... Furst, DE; + view all (2020) Abatacept in Early Diffuse Cutaneous Systemic Sclerosis - Results of a Phase 2 Investigator-Initiated, Multicenter, Double-Blind Randomized Placebo-Controlled Trial. Arthritis and Rheumatology , 72 (1) pp. 125-136. 10.1002/art.41055.


Moinzadeh, P; Frommolt, P; Franitza, M; Toliat, MR; Becker, K; Nürnberg, P; Nihtyanova, SI; ... Krieg, T; + view all (2020) Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsets. Journal of the European Academy of Dermatology and Venereology 10.1111/jdv.16198. (In press).


Ngcozana, T; Ong, VH; Denton, CP; (2020) Improving access to digital ulcer care through nurse-led clinic: a service evaluation. Musculoskeletal Care 10.1002/msc.1433. (In press).


Smith, V; Herrick, AL; Ingegnoli, F; Damjanov, N; Angelis, ; Denton, CP; Distler, O; ... EULAR Study Group on Microcirculation in Rheumatic Diseases and, ; + view all (2020) Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimmunity Reviews , Article 102458. 10.1016/j.autrev.2020.102458. (In press). Green open access

Standing, AS; Hong, Y; Paisan-Ruiz, C; Omoyinmi, E; Medlar, A; Stanescu, H; Kleta, R; ... Brogan, PA; + view all (2020) TRAP1 chaperone protein mutations and autoinflammation. Life Science Alliance , 3 (2) , Article e201900376. 10.26508/lsa.201900376. Green open access

Stock, CJW; De Lauretis, A; Visca, D; Daccord, C; Kokosi, M; Kouranos, V; Margaritopoulos, G; ... Renzoni, EA; + view all (2020) Defining genetic risk factors for scleroderma-associated interstitial lung disease. Clinical Rheumatology 10.1007/s10067-019-04922-6. (In press). Green open access


van Dam, LS; Osmani, Z; Kamerling, SWA; Kraaij, T; Bakker, JA; Scherer, HU; Rabelink, TJ; ... Teng, YKO; + view all (2020) A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE. Rheumatology 10.1093/rheumatology/kez623. (In press). Green open access

This list was generated on Sun Feb 2 21:28:38 2020 GMT.